Cite Filings / LIMN / 0001104659-26-082905
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

Liminatus Pharma, Inc. · Filed 2026-07-13 · Acc 0001104659-26-082905

Documents 1

  • DEF 14A Proxy Statement , tm264954-2_def14.htm

Around this filing

  • 2026-07-14 4 10% owner acquired 3,448,926 shares (other)
  • 2026-07-14 SCHEDULE 13D/A Beneficial Ownership Report
  • 2026-07-13 DEF 14A Proxy Statement
  • 2026-07-06 4 10% owner disposed of 4,373,603 shares (other)
  • 2026-07-06 3 Initial Statement of Ownership
  • 2026-07-06 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-07-06 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Bylaws or fiscal year change

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm264954-2_def14.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…